Author Index
Search or browse for an author across our entire electronic archive
Search results for: O
Results 391 - 400 of 688 shown below
-
Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies
doi:10.1038/sj.bjc.6605208
-
A Osorio, R L Milne, G Pita, P Peterlongo, T Heikkinen, J Simard, G Chenevix-Trench, A B Spurdle, J Beesley, X Chen, S Healey, S L Neuhausen, Y C Ding, F J Couch, X Wang, N Lindor, S Manoukian, M Barile, A Viel, L Tizzoni, C I Szabo, L Foretova, M Zikan, K Claes, M H Greene, P Mai, G Rennert, F Lejbkowicz, O Barnett-Griness, I L Andrulis, H Ozcelik, N Weerasooriya, A-M Gerdes, M Thomassen, D G Cruger, M A Caligo, E Friedman, B Kaufman, Y Laitman, S Cohen, T Kontorovich, R Gershoni-Baruch, E Dagan, H Jernström, M S Askmalm, B Arver, B Malmer, S M Domchek, K L Nathanson, J Brunet, T Ramón y Cajal, D Yannoukakos, U Hamann, F B L Hogervorst, S Verhoef, EB Gómez García, J T Wijnen, A van den Ouweland, D F Easton, S Peock, M Cook, C T Oliver, D Frost, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, J Cook, S Hodgson, P J Morrison, F Douglas, A K Godwin, O M Sinilnikova, L Barjhoux, D Stoppa-Lyonnet, V Moncoutier, S Giraud, C Cassini, L Olivier-Faivre, F Révillion, J-P Peyrat, D Muller, J-P Fricker, H T Lynch, E M John, S Buys, M Daly, J L Hopper, M B Terry, A Miron, Y Yassin, D Goldgar, C F Singer, D Gschwantler-Kaulich, G Pfeiler, A-C Spiess, Thomas v O Hansen, O T Johannsson, T Kirchhoff, K Offit, K Kosarin, M Piedmonte, G C Rodriguez, K Wakeley, J F Boggess, J Basil, P E Schwartz, S V Blank, A E Toland, M Montagna, C Casella, E N Imyanitov, A Allavena, R K Schmutzler, B Versmold, C Engel, A Meindl, N Ditsch, N Arnold, D Niederacher, H Dei
ler, B Fiebig, R Varon-Mateeva, D Schaefer, U G Froster, T Caldes, M de la Hoya, L McGuffog, A C Antoniou, H Nevanlinna, P Radice and J BenítezEvaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
advance online publication, 2009-11-17 00:00:00.000;
doi:10.1038/sj.bjc.6605416
-
A perspective on euthanasia
doi:10.1038/sj.bjc.6603365
-
Death and Medical Power: An Ethical Analysis of Dutch Euthanasia Practice
doi:10.1038/sj.bjc.6603373
-
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
doi:10.1038/sj.bjc.6690534
-
Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
doi:10.1054/bjoc.2000.1613
-
DNA topoisomerase I and II expression in drug resistantgerm cell tumours
doi:10.1038/sj.bjc.6600472
-
IPM chemotherapy in cytokine refractory renal cell cancer
doi:10.1038/sj.bjc.6600934
-
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
doi:10.1038/sj.bjc.6601176
-
Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding
advance online publication, 2004-11-30 00:00:00.000;
doi:10.1038/sj.bjc.6602263
-
GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
advance online publication, 2007-07-03 00:00:00.000;
doi:10.1038/sj.bjc.6603865
-
GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
doi:10.1038/sj.bjc.6604041
-
Risk factors for testicular germ cell tumours by histological tumour type
doi:10.1038/sj.bjc.6690611
-
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
doi:10.1054/bjoc.1999.1140
-
Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma
doi:10.1054/bjoc.2000.1480
-
A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
doi:10.1054/bjoc.2000.1498
-
Principles and practice of the biologic therapy of cancer (third edition)
doi:10.1038/sj.bjc.6600090
-
Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men
doi:10.1038/sj.bjc.6600946
-
Outcome of patients with HIV-related germ cell tumours: a case–control study
advance online publication, 2004-03-30 00:00:00.000;
doi:10.1038/sj.bjc.6601762
-
Long-term outcome among men with conservatively treated localised prostate cancer
doi:10.1038/sj.bjc.6603411
-
A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer
advance online publication, 2008-01-08 00:00:00.000;
doi:10.1038/sj.bjc.6604051
-
Role of biological markers in the clinical outcome of colon cancer
doi:10.1038/sj.bjc.6600569
-
Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays
doi:10.1038/sj.bjc.6600109
